Loading organizations...
Key people at Hibiscus Capital Management Fund II.
Hibiscus Capital Management Fund II is a venture capital fund focused on the biotechnology sector. Managed by Hibiscus Capital Management, the investment arm of Hibiscus BioVentures, the fund strategically backs innovative biopharmaceutical companies. It supports entities developing advanced therapeutic solutions and novel scientific platforms, aiming to foster significant advancements in life sciences.
Hibiscus Capital Management launched in 2020 as Hibiscus BioVentures’ dedicated investment vehicle, a specialized venture studio. The core insight combined focused capital with strategic guidance, accelerating biotechnology innovation. This structure allows the firm to apply deep industry expertise, identifying and nurturing high-potential life science ventures.
The fund primarily supports innovative biotechnology firms, guiding them through crucial development stages. Hibiscus Capital Management’s vision is to advance transformative medical innovations by providing essential resources and oversight. The firm aims to facilitate groundbreaking therapies, addressing critical global health needs.
Key people at Hibiscus Capital Management Fund II.
Hibiscus Capital Management Fund II has 1 tracked investment across 1 company. The latest tracked deal is $10.0M Series A in AsclepiX Therapeutics in July 2023.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jul 26, 2023 | AsclepiX Therapeutics | $10.0M Series A | Perceptive Advisors | Rapha Capital Management |
